{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T04:07:46Z","timestamp":1727410066869},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10549-024-07391-x","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:01:55Z","timestamp":1718359315000},"page":"633-640","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands"],"prefix":"10.1007","volume":"207","author":[{"given":"K. K.","family":"Rajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Nijveldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Verheijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Francken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"4","key":"7391_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11912-019-0777-3","volume":"21","author":"LJ Solin","year":"2019","unstructured":"Solin LJ (2019) Management of ductal carcinoma in situ (DCIS) of the breast: present approaches and future directions. Curr Oncol Rep 21(4):33. https:\/\/doi.org\/10.1007\/s11912-019-0777-3","journal-title":"Curr Oncol Rep"},{"key":"7391_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1570","volume":"369","author":"GS Mannu","year":"2020","unstructured":"Mannu GS, Wang Z, Broggio J, Charman J, Cheung S, Kearins O et al (2020) Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988\u20132014: population based observational cohort study. BMJ 369:m1570. https:\/\/doi.org\/10.1136\/bmj.m1570","journal-title":"BMJ"},{"issue":"7","key":"7391_CR3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888\u2013896. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2510","journal-title":"JAMA Oncol"},{"issue":"5","key":"7391_CR4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/sla.0000000000002239","volume":"267","author":"LE Elshof","year":"2018","unstructured":"Elshof LE, Schmidt MK, Rutgers EJT, van Leeuwen FE, Wesseling J, Schaapveld M (2018) Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ. Ann Surg 267(5):952\u2013958. https:\/\/doi.org\/10.1097\/sla.0000000000002239","journal-title":"Ann Surg"},{"issue":"12","key":"7391_CR5","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/cncr.25821","volume":"117","author":"AE Dragun","year":"2011","unstructured":"Dragun AE, Huang B, Tucker TC, Spanos WJ (2011) Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer. Cancer 117(12):2590\u20132598. https:\/\/doi.org\/10.1002\/cncr.25821","journal-title":"Cancer"},{"key":"7391_CR6","unstructured":"NKR: Overleving per jaren na diagnose. iknl.nl\/nkr-cijfers (2021). Accessed 13\/09\/2023 2023."},{"issue":"1","key":"7391_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-020-00888-0","volume":"13","author":"AG Dinmohamed","year":"2020","unstructured":"Dinmohamed AG, Lemmens V, de Hingh I, Visser O (2020) Relative survival in early-stage cancers in the Netherlands: a population-based study. J Hematol Oncol 13(1):49. https:\/\/doi.org\/10.1186\/s13045-020-00888-0","journal-title":"J Hematol Oncol"},{"issue":"3","key":"7391_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/jamainternmed.2019.6120","volume":"180","author":"AR Marcadis","year":"2020","unstructured":"Marcadis AR, Marti JL, Ehdaie B, Hakimi AA, Davies L, Morris LGT (2020) Characterizing relative and disease-specific survival in early-stage cancers. JAMA Intern Med 180(3):461\u2013463. https:\/\/doi.org\/10.1001\/jamainternmed.2019.6120","journal-title":"JAMA Intern Med"},{"issue":"3","key":"7391_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10549-020-05816-x","volume":"183","author":"EJ Groen","year":"2020","unstructured":"Groen EJ, Hudecek J, Mulder L, van Seijen M, Almekinders MM, Alexov S et al (2020) Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study. Breast Cancer Res Treat 183(3):759\u2013770. https:\/\/doi.org\/10.1007\/s10549-020-05816-x","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"7391_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4048\/jbc.2018.21.2.197","volume":"21","author":"M Kim","year":"2018","unstructured":"Kim M, Kim HJ, Chung YR, Kang E, Kim E-K, Kim SH et al (2018) Microinvasive carcinoma versus ductal carcinoma in situ: a comparison of clinicopathological features and clinical outcomes. J Breast Cancer 21(2):197\u2013205","journal-title":"J Breast Cancer"},{"key":"7391_CR11","unstructured":"Federatie Medisch Specialisten: Borstkanker - Aanbevelingen nacontrole. https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/nazorg_en_nacontrole\/signalering_en_behandeling_van_gevolgen\/aanbevelingen_nacontrole.html?query=controle#summary_literature (2021). Accessed 2021."},{"issue":"1","key":"7391_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejso.2005.10.005","volume":"32","author":"MJC van der Sangen","year":"2006","unstructured":"van der Sangen MJC, van de Poll-Franse LV, Roumen RMH, Rutten HJT, Coebergh JWW, Vreugdenhil G et al (2006) The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (EJSO) 32(1):34\u201338. https:\/\/doi.org\/10.1016\/j.ejso.2005.10.005","journal-title":"Eur J Surg Oncol (EJSO)"},{"issue":"3","key":"7391_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0167-8140(98)00118-2","volume":"50","author":"JJ Jager","year":"1999","unstructured":"Jager JJ, Volovics L, Schouten LJ, de Jong JMA, Hupperets PSGJ, von Meyenfeldt MF et al (1999) Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol 50(3):267\u2013275. https:\/\/doi.org\/10.1016\/S0167-8140(98)00118-2","journal-title":"Radiother Oncol"},{"issue":"1","key":"7391_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10549-020-06055-w","volume":"187","author":"JD Luiten","year":"2021","unstructured":"Luiten JD, Luiten EJT, van der Sangen MJC, Vreuls W, Duijm LEM, Tjan-Heijnen VCG et al (2021) Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands. Breast Cancer Res Treat 187(1):245\u2013254. https:\/\/doi.org\/10.1007\/s10549-020-06055-w","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7391_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10549-017-4613-x","volume":"168","author":"C Kim","year":"2018","unstructured":"Kim C, Liang L, Wright FC, Hong NJL, Groot G, Helyer L et al (2018) Interventions are needed to support patient\u2013provider decision-making for DCIS: a scoping review. Breast Cancer Res Treat 168(3):579\u2013592. https:\/\/doi.org\/10.1007\/s10549-017-4613-x","journal-title":"Breast Cancer Res Treat"},{"key":"7391_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2016.09.035","volume":"71","author":"MT King","year":"2017","unstructured":"King MT, Winters ZE, Olivotto IA, Spillane AJ, Chua BH, Saunders C et al (2017) Patient-reported outcomes in ductal carcinoma in situ: A systematic review. Eur J Cancer 71:95\u2013108. https:\/\/doi.org\/10.1016\/j.ejca.2016.09.035","journal-title":"Eur J Cancer"},{"issue":"5","key":"7391_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s12282-017-0765-0","volume":"24","author":"R Mercieca-Bebber","year":"2017","unstructured":"Mercieca-Bebber R, King MT, Boxer MM, Spillane A, Winters ZE, Butow PN et al (2017) What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions? Breast Cancer 24(5):720\u2013729. https:\/\/doi.org\/10.1007\/s12282-017-0765-0","journal-title":"Breast Cancer"},{"issue":"6","key":"7391_CR18","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.canep.2013.09.003","volume":"37","author":"L de Munck","year":"2013","unstructured":"de Munck L, Kwast A, Reiding D, de Bock GH, Otter R, Willemse PHB et al (2013) Attending the breast screening programme after breast cancer treatment: a population-based study. Cancer Epidemiol 37(6):968\u2013972. https:\/\/doi.org\/10.1016\/j.canep.2013.09.003","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"7391_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-022-06549-9","volume":"193","author":"JW Ankersmid","year":"2022","unstructured":"Ankersmid JW, Spronk PER, Zeillemaker AM, Siesling S (2022) Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty. Breast Cancer Res Treat 193(2):293\u2013303. https:\/\/doi.org\/10.1007\/s10549-022-06549-9","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7391_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ejon.2011.07.004","volume":"16","author":"I Grandjean","year":"2012","unstructured":"Grandjean I, Kwast AB, de Vries H, Klaase J, Schoevers WJ, Siesling S (2012) Evaluation of the adherence to follow-up care guidelines for women with breast cancer. Eur J Oncol Nurs 16(3):281\u2013285. https:\/\/doi.org\/10.1016\/j.ejon.2011.07.004","journal-title":"Eur J Oncol Nurs"},{"issue":"21","key":"7391_CR21","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","volume":"367","author":"A Bleyer","year":"2012","unstructured":"Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998\u20132005. https:\/\/doi.org\/10.1056\/NEJMoa1206809","journal-title":"N Engl J Med"},{"issue":"41","key":"7391_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","volume":"2010","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske K (2010) Epidemiology of Ductal Carcinoma In Situ. JNCI Monographs 2010(41):139\u2013141. https:\/\/doi.org\/10.1093\/jncimonographs\/lgq027","journal-title":"JNCI Monographs"},{"issue":"9","key":"7391_CR23","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1016\/S1470-2045(13)70135-9","volume":"14","author":"JR Benson","year":"2013","unstructured":"Benson JR, Wishart GC (2013) Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol 14(9):e348\u2013e357. https:\/\/doi.org\/10.1016\/S1470-2045(13)70135-9","journal-title":"Lancet Oncol"},{"issue":"3","key":"7391_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djp482","volume":"102","author":"BA Virnig","year":"2010","unstructured":"Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102(3):170\u2013178. https:\/\/doi.org\/10.1093\/jnci\/djp482","journal-title":"J Natl Cancer Inst"},{"key":"7391_CR25","unstructured":"Nederlandse Kankerregistratie: iknl.nl\/nkr-cijfers (2023). Accessed 02\u201302\u20132023."},{"issue":"02","key":"7391_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cdt3.21","volume":"08","author":"C Luo","year":"2022","unstructured":"Luo C, Wang L, Zhang Y, Lu M, Lu B, Cai J et al (2022) Advances in breast cancer screening modalities and status of global screening programs. Chron Dis Translat Med 08(02):112\u2013123. https:\/\/doi.org\/10.1002\/cdt3.21","journal-title":"Chron Dis Translat Med"},{"issue":"10","key":"7391_CR27","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1093\/oncolo\/oyac126","volume":"27","author":"T Draeger","year":"2022","unstructured":"Draeger T, Voelkel V, Schreuder K, Veltman J, Dassen A, Strobbe L et al (2022) Adherence to the dutch breast cancer guidelines for surveillance in breast cancer survivors: real-world data from a pooled multicenter analysis. Oncologist 27(10):e766\u2013e773. https:\/\/doi.org\/10.1093\/oncolo\/oyac126","journal-title":"Oncologist"},{"issue":"4","key":"7391_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1200\/jop.200009","volume":"6","author":"E Grunfeld","year":"2010","unstructured":"Grunfeld E, Hodgson DC, Giudice MED, Moineddin R (2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6(4):174\u2013181. https:\/\/doi.org\/10.1200\/jop.200009","journal-title":"J Oncol Pract"},{"issue":"1","key":"7391_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1471-2407-11-279","volume":"11","author":"W Lu","year":"2011","unstructured":"Lu W, Jansen L, Schaapveld M, Baas PC, Wiggers T, De Bock GH (2011) Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer 11(1):279. https:\/\/doi.org\/10.1186\/1471-2407-11-279","journal-title":"BMC Cancer"},{"issue":"5","key":"7391_CR30","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.3390\/curroncol30050359","volume":"30","author":"F Borella","year":"2023","unstructured":"Borella F, Bertero L, Di Giovanni F, Witel G, Orlando G, Ricci AA et al (2023) COVID-19 and breast cancer: analysis of surgical management of a large referral center during the 2020\u20132021 pandemic period. Curr Oncol 30(5):4767\u20134778","journal-title":"Curr Oncol"},{"key":"7391_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-022-01178-z","author":"JW Ankersmid","year":"2022","unstructured":"Ankersmid JW, Drossaert CHC, van Riet YEA, Strobbe LJA, Siesling S, Santeon VBCG (2022) Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance. J Cancer Survivorship. https:\/\/doi.org\/10.1007\/s11764-022-01178-z","journal-title":"J Cancer Survivorship"},{"issue":"2","key":"7391_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10549-022-06563-x","volume":"193","author":"P Santi\u00e1","year":"2022","unstructured":"Santi\u00e1 P, Jansana A, del Cura I, Padilla-Ruiz M, Domingo L, Louro J et al (2022) Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort. Breast Cancer Res Treat 193(2):455\u2013465. https:\/\/doi.org\/10.1007\/s10549-022-06563-x","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"7391_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/030089161109700503","volume":"97","author":"S Barni","year":"2011","unstructured":"Barni S, Venturini M, Molino A, Donadio M, Rizzoli S, Maiello E et al (2011) Importance of adherence to guidelines in breast cancer clinical practice. the Italian experience (AIOM). Tumori J 97(5):559\u2013563. https:\/\/doi.org\/10.1177\/030089161109700503","journal-title":"Tumori J"},{"key":"7391_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejca.2018.07.003","volume":"101","author":"MC van Maaren","year":"2018","unstructured":"van Maaren MC, Lagendijk M, Tilanus-Linthorst MMA, de Munck L, Pijnappel RM, Schmidt MK et al (2018) Breast cancer\u2013related deaths according to grade in ductal carcinoma in situ: a Dutch population\u2013based study on patients diagnosed between 1999 and 2012. Eur J Cancer 101:134\u2013142. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.003","journal-title":"Eur J Cancer"},{"issue":"12","key":"7391_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N et al (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ\u2013The LORD study. Eur J Cancer 51(12):1497\u20131510. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.008","journal-title":"Eur J Cancer"},{"issue":"16","key":"7391_CR36","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JMS, Brookes C et al (2015) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51(16):2296\u20132303. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.017","journal-title":"Eur J Cancer"},{"issue":"3","key":"7391_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ypmed.2011.06.009","volume":"53","author":"R de Gelder","year":"2011","unstructured":"de Gelder R, Fracheboud J, Heijnsdijk EAM, den Heeten G, Verbeek ALM, Broeders MJM et al (2011) Digital mammography screening: Weighing reduced mortality against increased overdiagnosis. Prev Med 53(3):134\u2013140. https:\/\/doi.org\/10.1016\/j.ypmed.2011.06.009","journal-title":"Prev Med"},{"issue":"10","key":"7391_CR38","first-page":"A5218","volume":"157","author":"ALM Verbeek","year":"2013","unstructured":"Verbeek ALM, Broeders MJM, Otto SJ, Frachebou J, Otten JDMH, Holland R et al (2013) Effects of the population screening into breast cancer. Ned Tijdschr Geneeskd 157(10):A5218","journal-title":"Ned Tijdschr Geneeskd"},{"key":"7391_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"EJ Groen","year":"2017","unstructured":"Groen EJ, Elshof LE, Visser LL, Rutgers EJT, Winter-Warnars HAO, Lips EH et al (2017) Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast 31:274\u2013283. https:\/\/doi.org\/10.1016\/j.breast.2016.09.001","journal-title":"Breast"},{"issue":"2","key":"7391_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-019-05401-x","volume":"178","author":"C-Y Lin","year":"2019","unstructured":"Lin C-Y, Vennam S, Purington N, Lin E, Varma S, Han S et al (2019) Genomic landscape of ductal carcinoma in situ and association with progression. Breast Cancer Res Treat 178(2):307\u2013316. https:\/\/doi.org\/10.1007\/s10549-019-05401-x","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7391_CR41","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","volume":"105","author":"LJ Solin","year":"2013","unstructured":"Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C et al (2013) A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Ins 105(10):701\u2013710. https:\/\/doi.org\/10.1093\/jnci\/djt067","journal-title":"J Natl Cancer Ins"},{"issue":"3","key":"7391_CR42","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10549-021-06335-z","volume":"189","author":"V V\u00f6lkel","year":"2021","unstructured":"V\u00f6lkel V, Hueting TA, Draeger T, van Maaren MC, de Munck L, Strobbe LJA et al (2021) Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE model. Breast Cancer Res Treat 189(3):817\u2013826. https:\/\/doi.org\/10.1007\/s10549-021-06335-z","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"7391_CR43","doi-asserted-by":"publisher","first-page":"e1330","DOI":"10.1634\/theoncologist.2019-0973","volume":"25","author":"A Witteveen","year":"2020","unstructured":"Witteveen A, de Munck L, Groothuis-Oudshoorn CGM, Sonke GS, Poortmans PM, Boersma LJ et al (2020) Evaluating the age-based recommendations for long-term follow-up in breast cancer. Oncologist 25(9):e1330\u2013e1338. https:\/\/doi.org\/10.1634\/theoncologist.2019-0973","journal-title":"Oncologist"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07391-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T03:46:56Z","timestamp":1727322416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07391-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7391"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07391-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of the Isala Hospital determined that the protocol did not require medical ethical approval according to the Dutch Medical Ethics Law.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}